Karima Oualla: We invite you to fill out this survey that takes no more than 3 minutes to complete.

Quoting Karima Oualla, Professor of Medical Oncology at Hassan II University Hospital, on LinkedIn:

“Dear Colleagues,

We are conducting a survey-based study on the preferences, experience, and common practices of oncologists about CDK4/6 inhibitors use in advanced ER+/HER2- breast cancer. In addition, we focus on the patterns and preferences for post-progression systemic therapies used.

This will help us to understand the disease and the response to treatment in a better way. We invite you to fill out this survey that takes no more than 3 minutes to complete.”

Source: Karima Oualla/LinkedIn